Abstract
Erectile dysfunction (ED) is a cause of decreased quality of life in more than 70% of diabetic men. Vascular endothelial growth factor (VEGF) has shown to improve overall endothelial and smooth muscle cell dysfunction in models of ED. We describe a novel technique for nonviral, in vivo gene transfection of VEGF in the rat corpus cavernosum. Diabetic rats were transfected with DNA encoding a fusion VEGF/green fluorescent protein (GFP) complex and fluorescence microscopy was used to monitor the expression of VEGF–GFP fusion protein. Western blot and PCR analyses confirmed the expression of the GFP–VEGF fusion protein and mRNA. Functional studies using cavernous nerve stimulation revealed maximal intracavernous pressures (ICPs) of 63.1 mm Hg, and 30.7 mm Hg in the normal and diabetic control groups, respectively, and 47.4 mm Hg in VEGF–GFP-transfected diabetic group. Immunohistochemical analysis of the cavernosal tissue from transfected rats showed increased smooth muscle content compared with the diabetic control group. We show for the first time in our animal model that expression of the transfected VEGF in cavernosal tissue leads to an overall improvement of maximal ICP and smooth muscle content. On the basis of these results, it is tempting to speculate that our nonviral vector system offers an excellent system for gene delivery into cavernosal tissue, and that VEGF gene therapy using this system could be useful in improving erectile function in diabetic men.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rogers RS, Graziottin TM, Lin CS, Lue TF . Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Imp Res 2003; 15: 26–37.
Christ GJ, Day N, Santizo C, Sato Y, Zhao W, Sclafani T et al. Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. Am J Physiol Heart Circ Physiol 2004; 287: H1544–H1553.
Melman A, Bar-Chama N, McCullough A, Davies K, Christ G . hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial. Hum Gene Ther 2006; 17: 1165–1176.
Chancellor MB, Tirney S, Mattes CE, Tzeng E, Birder LA, Kanai AJ et al. Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. BJU Int 2003; 91: 691–696.
Bivalacqua TJ, Usta MF, Champion HC, Adams D, Namara DB, Abdel-Mageed AB et al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 2003; 169: 1911–1917.
Shen ZJ, Wang H, Lu YL, Zhou XL, Chen SW, Chen ZD . Gene transfer of vasoactive intestinal polypeptide into the penis improves erectile response in the diabetic rat. BJU Int 2005; 95: 890–894.
Gholami SS, Rogers R, Chang J, Ho HC, Grazziottin T, Lin CS et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003; 169: 1577–1581.
Magee TR, Ferrini M, Garban HJ, Vernet D, Mitani K, Rajfer J et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002; 67: 20–28.
Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297–7301.
Lee M, Ryu JK, Oh SM, Lee E, Shin HY, Song SU et al. Water-soluble lipopolymer as a gene carrier to corpus cavernosum. Int J Imp Res 2005; 17: 326–334.
Kichler A . Gene transfer with modified polyethylenimines. J Gene Med 2004; 6: S3–S10.
Ryu JK, Cho CH, Shin HY, Song SU, Oh SM, Lee M et al. Combined angiopoietin-1 and vascular endothelial growth factor gene transfer restores cavernous angiogenesis and erectile function in a rat model of hypercholesterolemia. Mol Ther 2006; 13: 705–715.
Yamanaka M, Shirai M, Shiina H, Tanaka Y, Enokida H, Tsujimura A et al. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol 2005; 173: 318–323.
Shirai M, Yamanaka M, Shiina H, Igawa M, Kawakami T, Ishii N et al. Vascular endothelial growth factor restores erectile function through modulation of the insulin-like growth factor system and sex hormone receptors in diabetic rat. Biochem Biophys Res Commun 2006; 341: 755–762.
Gerber HP, Dixit V, Ferrara N . Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313–13316.
Nor JE, Christensen J, Mooney DJ, Polverini PJ . Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999; 154: 375–384.
Koul S, Johnson T, Meacham RB, Koul HK . Cloning and characterization of VEGF from LnCaP cells, a line of prostate cancer cells, LOCUS AY766116, http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=54401694.
Dall'Era JE, Koul S, Mills JN, Myers J, Meacham RB, Koul HK . In-vivo transfection of the rat corpus cavernosum using a non-viral, linear polyethylenimine gene delivery system: a novel application (abstract no.; 1004, AUA annual meeting, 2006, Atlanta).
Ahn GJ, Sohn YS, Kang KK, Ahn BO, Kwon JW, Kang SK et al. The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats. Int J Imp Res 2005; 17: 134–141.
Acknowledgements
This study was supported in part by UCDHSC SOM and the Department of Surgery AEF grant support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dall'Era, J., Meacham, R., Mills, J. et al. Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model. Int J Impot Res 20, 307–314 (2008). https://doi.org/10.1038/ijir.2008.1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2008.1
Keywords
This article is cited by
-
Vasohibin-1 rescues erectile function through up-regulation of angiogenic factors in the diabetic mice
Scientific Reports (2021)
-
Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90β/eNOS complex
Diabetologia (2020)
-
Dickkopf2 rescues erectile function by enhancing penile neurovascular regeneration in a mouse model of cavernous nerve injury
Scientific Reports (2017)
-
Molecular mechanisms associated with diabetic endothelial–erectile dysfunction
Nature Reviews Urology (2016)
-
Designed angiopoietin-1 variant, COMP-angiopoietin-1, rescues erectile function through healthy cavernous angiogenesis in a hypercholesterolemic mouse
Scientific Reports (2015)